These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 34420839)

  • 1. Systematic Review and Network Meta-analysis: Efficacy and Safety of Second-Generation Antipsychotics in Youths With Bipolar Depression.
    DelBello MP; Kadakia A; Heller V; Singh R; Hagi K; Nosaka T; Loebel A
    J Am Acad Child Adolesc Psychiatry; 2022 Feb; 61(2):243-254. PubMed ID: 34420839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of atypical antipsychotics for acute bipolar depression: a network meta-analysis.
    Kadakia A; Dembek C; Heller V; Singh R; Uyei J; Hagi K; Nosaka T; Loebel A
    BMC Psychiatry; 2021 May; 21(1):249. PubMed ID: 33975574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lurasidone compared to other atypical antipsychotic monotherapies for bipolar depression: A systematic review and network meta-analysis.
    Ostacher M; Ng-Mak D; Patel P; Ntais D; Schlueter M; Loebel A
    World J Biol Psychiatry; 2018 Dec; 19(8):586-601. PubMed ID: 28264635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second-Generation Antipsychotics in Management of Acute Pediatric Bipolar Depression: A Systematic Review and Meta-analysis.
    Patel RS; Veluri N; Patel J; Patel R; Machado T; Diler R
    J Child Adolesc Psychopharmacol; 2021 Oct; 31(8):521-530. PubMed ID: 34665020
    [No Abstract]   [Full Text] [Related]  

  • 5. Lurasidone, olanzapine, and quetiapine extended-release for bipolar depression: A systematic review and network meta-analysis of phase 3 trials in Japan.
    Kishi T; Yoshimura R; Sakuma K; Okuya M; Iwata N
    Neuropsychopharmacol Rep; 2020 Dec; 40(4):417-422. PubMed ID: 32902200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis.
    De Hert M; Yu W; Detraux J; Sweers K; van Winkel R; Correll CU
    CNS Drugs; 2012 Sep; 26(9):733-59. PubMed ID: 22900950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of FDA-approved atypical antipsychotics for the treatment of bipolar depression: a systematic review and network meta-analysis.
    Li S; Xu C; Hu S; Lai J
    Eur Psychiatry; 2024 Mar; 67(1):e29. PubMed ID: 38487836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy and tolerability of pharmacological interventions for acute bipolar depression in adults: a systematic review and network meta-analysis.
    Yildiz A; Siafis S; Mavridis D; Vieta E; Leucht S
    Lancet Psychiatry; 2023 Sep; 10(9):693-705. PubMed ID: 37595997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lurasidone compared to other atypical antipsychotic monotherapies for adolescent schizophrenia: a systematic literature review and network meta-analysis.
    Arango C; Ng-Mak D; Finn E; Byrne A; Loebel A
    Eur Child Adolesc Psychiatry; 2020 Sep; 29(9):1195-1205. PubMed ID: 31758359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical assessment of lurasidone benefit and risk in the treatment of bipolar I depression using number needed to treat, number needed to harm, and likelihood to be helped or harmed.
    Citrome L; Ketter TA; Cucchiaro J; Loebel A
    J Affect Disord; 2014 Feb; 155():20-7. PubMed ID: 24246116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Balancing benefits and harms of treatments for acute bipolar depression.
    Ketter TA; Miller S; Dell'Osso B; Calabrese JR; Frye MA; Citrome L
    J Affect Disord; 2014 Dec; 169 Suppl 1():S24-33. PubMed ID: 25533911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of bipolar depression: making sensible decisions.
    Citrome L
    CNS Spectr; 2014 Dec; 19 Suppl 1():4-11; quiz 1-3, 12. PubMed ID: 25407667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy and tolerability of pharmacological treatments for the treatment of acute bipolar depression: A systematic review and network meta-analysis.
    Bahji A; Ermacora D; Stephenson C; Hawken ER; Vazquez G
    J Affect Disord; 2020 May; 269():154-184. PubMed ID: 32339131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Important clinical features of atypical antipsychotics in acute bipolar depression that inform routine clinical care: a review of pivotal studies with number needed to treat.
    Gao K; Yuan C; Wu R; Chen J; Wang Z; Fang Y; Calabrese JR
    Neurosci Bull; 2015 Oct; 31(5):572-88. PubMed ID: 26024955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of atypical antipsychotics for unipolar and bipolar depression in adolescents and young adults: A systematic review and meta-analysis.
    Garcia-Rodriguez L; Burton DJ; Leonards CA; Davey CG
    J Affect Disord; 2023 Oct; 339():633-639. PubMed ID: 37467794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olanzapine/Fluoxetine combination in children and adolescents with bipolar I depression: a randomized, double-blind, placebo-controlled trial.
    Detke HC; DelBello MP; Landry J; Usher RW
    J Am Acad Child Adolesc Psychiatry; 2015 Mar; 54(3):217-24. PubMed ID: 25721187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of FDA-approved treatment options in bipolar depression.
    McIntyre RS; Cha DS; Kim RD; Mansur RB
    CNS Spectr; 2013 Dec; 18 Suppl 1():4-20; quiz 21. PubMed ID: 24237641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lurasidone in Children and Adolescents with Bipolar Depression Presenting with Mixed (Subsyndromal Hypomanic) Features:
    Singh MK; Pikalov A; Siu C; Tocco M; Loebel A
    J Child Adolesc Psychopharmacol; 2020 Dec; 30(10):590-598. PubMed ID: 32392455
    [No Abstract]   [Full Text] [Related]  

  • 19. Tolerability, Safety, and Effectiveness of Two Years of Treatment with Lurasidone in Children and Adolescents with Bipolar Depression.
    DelBello MP; Tocco M; Pikalov A; Deng L; Goldman R
    J Child Adolesc Psychopharmacol; 2021 Sep; 31(7):494-503. PubMed ID: 34324397
    [No Abstract]   [Full Text] [Related]  

  • 20. Hospitalization risk among adults with bipolar I disorder treated with lurasidone versus other oral atypical antipsychotics: a retrospective analysis of Medicaid claims data.
    Niu X; Veeranki P; Dennen S; Dembek C; Laubmeier K; Liu Y; Williams GR; Loebel A
    Curr Med Res Opin; 2021 May; 37(5):839-846. PubMed ID: 33682547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.